BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8498505)

  • 1. Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model.
    Caumo A; Cobelli C
    Am J Physiol; 1993 May; 264(5 Pt 1):E829-41. PubMed ID: 8498505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT.
    Cobelli C; Pacini G; Toffolo G; SaccĂ  L
    Am J Physiol; 1986 May; 250(5 Pt 1):E591-8. PubMed ID: 3518490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT.
    Krudys KM; Dodds MG; Nissen SM; Vicini P
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1038-46. PubMed ID: 15632105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal models of glucose disappearance: lessons from the labelled IVGTT.
    Caumo A; Giacca A; Morgese M; Pozza G; Micossi P; Cobelli C
    Diabet Med; 1991 Nov; 8(9):822-32. PubMed ID: 1837509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic insulin sensitivity assessed by integrated model of hepatic and peripheral glucose regulation.
    Tokuyama K; Nagasaka S; Mori S; Takahashi N; Kusaka I; Kiyonaga A; Tanaka H; Shindo M; Ishibashi S
    Diabetes Technol Ther; 2009 Aug; 11(8):487-92. PubMed ID: 19698061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models.
    Regittnig W; Trajanoski Z; Leis HJ; Ellmerer M; Wutte A; Sendlhofer G; Schaupp L; Brunner GA; Wach P; Pieber TR
    Diabetes; 1999 May; 48(5):1070-81. PubMed ID: 10331412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach.
    Vicini P; Avogaro A; Spilker ME; Gallo A; Cobelli C
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E78-84. PubMed ID: 12067846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian two-compartment and classic single-compartment minimal models: comparison on insulin modified IVGTT and effect of experiment reduction.
    Callegari T; Caumo A; Cobelli C
    IEEE Trans Biomed Eng; 2003 Dec; 50(12):1301-9. PubMed ID: 14656059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity.
    Vicini P; Caumo A; Cobelli C
    Am J Physiol; 1997 Nov; 273(5):E1024-32. PubMed ID: 9374690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility and comparability of insulin sensitivity indices measured by stable-label intravenous glucose tolerance test.
    Hovorka R; Bannister P; Eckland DJ; Halliday D; Murley DN; Rees SE; Young MA
    Diabet Med; 1998 Mar; 15(3):234-46. PubMed ID: 9545125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated model of insulin and glucose kinetics describing both hepatic glucose and pancreatic insulin regulation.
    Erlandsen M; Martinussen C; Gravholt CH
    Comput Methods Programs Biomed; 2018 Mar; 156():121-131. PubMed ID: 29428063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrated glucose insulin minimal model: An improved version.
    Ibrahim MMA; Largajolli A; Karlsson MO; Kjellsson MC
    Eur J Pharm Sci; 2019 Jun; 134():7-19. PubMed ID: 30978382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion.
    Toffolo G; De Grandi F; Cobelli C
    Diabetes; 1995 Jul; 44(7):845-54. PubMed ID: 7789653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overestimation of minimal model glucose effectiveness in presence of insulin response is due to undermodeling.
    Cobelli C; Bettini F; Caumo A; Quon MJ
    Am J Physiol; 1998 Dec; 275(6):E1031-6. PubMed ID: 9843746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of labeled oral minimal model to measure hepatic insulin sensitivity.
    Man CD; Toffolo G; Basu R; Rizza RA; Cobelli C
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1152-9. PubMed ID: 18765681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling glucose metabolism in man: theory and practice.
    Cobelli C; Bier DM; Ferrannini E
    Horm Metab Res Suppl; 1990; 24():1-10. PubMed ID: 2272612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of glucose effectiveness and insulin sensitivity from minimal model analysis: a theoretical evaluation of the single-compartment glucose distribution assumption.
    Ni TC; Ader M; Bergman RN
    Diabetes; 1997 Nov; 46(11):1813-21. PubMed ID: 9356031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological issues in the application of the minimal model: effects of glucose dose, basal glucose concentration, test duration and modelling constraint.
    Godsland IF; Luzio S; Wynn V; Owens DR
    Diabetes Res; 1994; 26(4):139-53. PubMed ID: 7648789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.
    Ward GM; Walters JM; Barton J; Alford FP; Boston RC
    Metabolism; 2001 May; 50(5):512-9. PubMed ID: 11319711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT.
    Hovorka R; Shojaee-Moradie F; Carroll PV; Chassin LJ; Gowrie IJ; Jackson NC; Tudor RS; Umpleby AM; Jones RH
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E992-1007. PubMed ID: 11934663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.